{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:18Z","timestamp":1787026338364,"version":"build-2736575974"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Despite developments in circulating biomarker and imaging technology in the assessment of cardiovascular disease, the surveillance and diagnosis of heart transplant rejection has continued to rely on histopathologic interpretation of the endomyocardial biopsy. Increasing evidence shows the utility of molecular evaluations, such as donor-specific antibodies and donor-derived cell-free DNA, as well as advanced imaging techniques, such as cardiac magnetic resonance imaging, in the assessment of rejection, resulting in the elimination of many surveillance endomyocardial biopsies. As non-invasive technologies in heart transplant rejection continue to evolve and are incorporated into practice, they may supplant endomyocardial biopsy even when rejection is suspected, allowing for more precise and expeditious rejection therapy. This review describes the current and near-future states for the evaluation of heart transplant rejection, both in the settings of rejection surveillance and rejection diagnosis. As biomarkers of rejection continue to evolve, rejection risk prediction may allow for a more personalized approach to immunosuppression.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1349376","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T23:49:27Z","timestamp":1707176967000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A gentler approach to monitor for heart transplant rejection"],"prefix":"10.3389","volume":"11","author":[{"given":"Jason F.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder K.","family":"Bahniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamacardio.2019.4748","article-title":"Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C","volume":"5","author":"Schlendorf","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101887","DOI":"10.1016\/j.eclinm.2023.101887","article-title":"The international experience of in-situ recovery of the DCD heart: a multicentre retrospective observational study","volume":"58","author":"Louca","year":"2023","journal-title":"eClinicalMedicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e009923","DOI":"10.1161\/circheartfailure.122.009923","article-title":"Clinical prediction model for antibody-mediated rejection: a strategy to minimize surveillance endomyocardial biopsies after heart transplantation","volume":"15","author":"Coutance","year":"2022","journal-title":"Circ Hear Fail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/circulationaha.120.049098","article-title":"Cell-free DNA to detect heart allograft acute rejection","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/tp.0b013e31826e19e2","article-title":"Concordance among pathologists in the second cardiac allograft rejection gene expression observational study (CARGO II)","volume":"94","author":"Crespo-Leiro","year":"2012","journal-title":"Transplant J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jchf.2022.08.005","article-title":"Safety of right and left ventricular endomyocardial biopsy in heart transplantation and cardiomyopathy patients","volume":"10","author":"Bermpeis","year":"2022","journal-title":"Jacc Hear Fail"},{"key":"B8","doi-asserted-by":"publisher","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"DeVlaminck","year":"2014","journal-title":"Sci Transl Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/nejmoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"New Engl J Medicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/circheartfailure.114.001658","article-title":"Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant","volume":"8","author":"Kobashigawa","year":"2015","journal-title":"Circulation Hear Fail"},{"key":"B12","year":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"e14699","DOI":"10.1111\/ctr.14699","article-title":"Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation","volume":"37","author":"Henricksen","year":"2023","journal-title":"Clin Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e14258","DOI":"10.1111\/ctr.14258","article-title":"Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients","volume":"35","author":"Gondi","year":"2021","journal-title":"Clin Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.healun.2003.08.005","article-title":"Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection","volume":"23","author":"Arnau-Vives","year":"2004","journal-title":"J Hear Lung Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1444.e5","DOI":"10.1016\/j.healun.2004.08.018","article-title":"B-type natriuretic peptide as a marker of allograft rejection after heart transplantation","volume":"24","author":"Hammerer-Lercher","year":"2005","journal-title":"J Hear Lung Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/tp.0000000000000378","article-title":"Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients","volume":"99","author":"Battes","year":"2015","journal-title":"Transplantation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/tp.0000000000003876","article-title":"High-sensitivity cardiac troponin is not associated with acute cellular rejection after heart transplantation","volume":"106","author":"Fitzsimons","year":"2022","journal-title":"Transplantation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/01.cir.102.17.2100","article-title":"Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients","volume":"102","author":"Eisenberg","year":"2000","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.healun.2017.07.012","article-title":"Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection","volume":"37","author":"Kennel","year":"2018","journal-title":"J Hear Lung Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.healun.2021.07.024","article-title":"Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation","volume":"40","author":"Truby","year":"2021","journal-title":"J Hear Lung Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report \u2014 2019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Hear Lung Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.healun.2015.10.035","article-title":"ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: a retrospective validation analysis","volume":"35","author":"Hammond","year":"2016","journal-title":"J Hear Lung Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of Nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Hear Lung Transplant"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 international society for heart and lung transplantation working formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Hear Lung Transplant"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e13416","DOI":"10.1111\/ctr.13416","article-title":"De novo donor-specific HLA antibodies in heart transplantation: do transient de novo DSA confer the same risk as persistent de novo DSA?","volume":"32","author":"Moayedi","year":"2018","journal-title":"Clin Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e13121","DOI":"10.1111\/ctr.13121","article-title":"The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation","volume":"31","author":"Torres","year":"2017","journal-title":"Clin Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e14483","DOI":"10.1111\/ctr.14483","article-title":"The effects of donor-specific antibody characteristics on cardiac allograft vasculopathy","volume":"35","author":"Wang","year":"2021","journal-title":"Clin Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/ajt.14691","article-title":"Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: a report from the CTOTC-04 study","volume":"18","author":"Dipchand","year":"2018","journal-title":"Am J Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/cir.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12026-009-8154-1","article-title":"Immunogenetics and immunology in transplantation","volume":"47","author":"Zachary","year":"2010","journal-title":"Immunol Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e12924","DOI":"10.1111\/ctr.12924","article-title":"De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation","volume":"31","author":"Cole","year":"2017","journal-title":"Clin Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.healun.2015.05.001","article-title":"Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation","volume":"34","author":"Irving","year":"2015","journal-title":"J Hear Lung Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jcmg.2018.10.027","article-title":"Native T1 mapping in the diagnosis of cardiac allograft rejection A prospective histologically validated study","volume":"12","author":"Imran","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jcmg.2019.01.026","article-title":"Multiparametric cardiac magnetic resonance imaging can detect acute cardiac allograft rejection after heart transplantation","volume":"12","author":"Dolan","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1161\/circulationaha.121.057006","article-title":"Cardiovascular magnetic resonance for rejection surveillance after cardiac transplantation","volume":"145","author":"Anthony","year":"2022","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.ejcts.2009.11.037","article-title":"Strain rate imaging would predict sub-clinical acute rejection in heart transplant recipients","volume":"37","author":"Kato","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.echo.2014.12.013","article-title":"Myocardial strain and strain rate from speckle-tracking echocardiography are unable to differentiate asymptomatic biopsy-proven cellular rejection in the first year after cardiac transplantation","volume":"28","author":"Ambardekar","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1111\/echo.14544","article-title":"Myocardial deformation and acute cellular rejection after heart transplantation: impact of inter-vendor variability in diagnostic effectiveness","volume":"36","author":"Ruiz-Ortiz","year":"2019","journal-title":"Echocardiography"},{"key":"B40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.healun.2017.11.003","article-title":"Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation","volume":"37","author":"Cole","year":"2018","journal-title":"J Hear Lung Transplant"},{"key":"B41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.healun.2017.01.003","article-title":"Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada","volume":"36","author":"Clarke","year":"2017","journal-title":"J Hear Lung Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","article-title":"MicroRNAs as non-invasive biomarkers of heart transplant rejection","volume":"35","author":"DuongVanHuyen","year":"2014","journal-title":"Eur Heart J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.healun.2022.06.019","article-title":"Circulating microRNAs in cellular and antibody-mediated heart transplant rejection","volume":"41","author":"Shah","year":"2022","journal-title":"J Hear Lung Transplant"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.09.023","article-title":"The international society for heart and lung transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Hear Lung Transplant"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1161\/circulationaha.119.044924","article-title":"Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation","volume":"141","author":"Loupy","year":"2020","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.healun.2009.12.015","article-title":"Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes","volume":"29","author":"Kobashigawa","year":"2010","journal-title":"J Hear Lung Transplant"},{"key":"B47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.healun.2008.10.001","article-title":"Assessment of the cylex ImmuKnow cell function assay in pediatric heart transplant patients","volume":"28","author":"Rossano","year":"2009","journal-title":"J Hear Lung Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.trre.2019.03.004","article-title":"Torque-teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation","volume":"33","author":"Rezahosseini","year":"2019","journal-title":"Transplant Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/ajt.13421","article-title":"RNA profiling in human and murine transplanted hearts: identification and validation of therapeutic targets for acute cardiac and renal allograft rejection","volume":"16","author":"Aelst","year":"2016","journal-title":"Am J Transplant"},{"key":"B50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.healun.2019.11.015","article-title":"Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation","volume":"39","author":"Richmond","year":"2020","journal-title":"J Hear Lung Transplant"},{"key":"B51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.healun.2022.04.002","article-title":"A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation","volume":"41","author":"Kim","year":"2022","journal-title":"J Hear Lung Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/cvr\/cvw244","article-title":"Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through down-regulation of endothelial RAB11FIP2 expression","volume":"113","author":"Dewi","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.healun.2020.05.018","article-title":"Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation","volume":"39","author":"Constanso-Conde","year":"2020","journal-title":"J Hear Lung Transplant"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1349376\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T12:18:09Z","timestamp":1713269889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1349376\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":53,"alternative-id":["10.3389\/fcvm.2024.1349376"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1349376","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"article-number":"1349376"}}